160 related articles for article (PubMed ID: 24165314)
1. Features of occult invasion in biopsy-proven DCIS at breast MRI.
Wisner DJ; Hwang ES; Chang CB; Tso HH; Joe BN; Lessing JN; Lu Y; Hylton NM
Breast J; 2013; 19(6):650-8. PubMed ID: 24165314
[TBL] [Abstract][Full Text] [Related]
2. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
3. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
[TBL] [Abstract][Full Text] [Related]
5. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
6. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
[TBL] [Abstract][Full Text] [Related]
7. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.
Goto M; Yuen S; Akazawa K; Nishida K; Konishi E; Kajihara M; Shinkura N; Yamada K
Eur Radiol; 2012 Jun; 22(6):1255-64. PubMed ID: 22205445
[TBL] [Abstract][Full Text] [Related]
8. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
[TBL] [Abstract][Full Text] [Related]
9. Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions.
Lunkiewicz M; Forte S; Freiwald B; Singer G; Leo C; Kubik-Huch RA
Eur Radiol; 2020 Jan; 30(1):77-86. PubMed ID: 31392476
[TBL] [Abstract][Full Text] [Related]
10. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
[TBL] [Abstract][Full Text] [Related]
11. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
[TBL] [Abstract][Full Text] [Related]
12. Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
Harowicz MR; Saha A; Grimm LJ; Marcom PK; Marks JR; Hwang ES; Mazurowski MA
J Magn Reson Imaging; 2017 Nov; 46(5):1332-1340. PubMed ID: 28181348
[TBL] [Abstract][Full Text] [Related]
13. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.
Lee KH; Han JW; Kim EY; Yun JS; Park YL; Park CH
BMC Cancer; 2019 Dec; 19(1):1201. PubMed ID: 31822268
[TBL] [Abstract][Full Text] [Related]
16. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
17. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
18. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.
Tozaki M
Breast Cancer; 2013 Jan; 20(1):13-20. PubMed ID: 22109641
[TBL] [Abstract][Full Text] [Related]
19. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
[TBL] [Abstract][Full Text] [Related]
20. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
